nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—GPCR ligand binding—CCL22—atopic dermatitis	0.000572	0.0231	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—TRPV3—atopic dermatitis	0.000555	0.0224	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—TRPV3—atopic dermatitis	0.000545	0.022	CbGpPWpGaD
Acamprosate—GRM5—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000531	0.0214	CbGpPWpGaD
Acamprosate—GRM5—G alpha (q) signalling events—NPS—atopic dermatitis	0.000531	0.0214	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000521	0.021	CbGpPWpGaD
Acamprosate—Malaise—Triamcinolone—atopic dermatitis	0.000515	0.000528	CcSEcCtD
Acamprosate—Anxiety—Hydrocortisone—atopic dermatitis	0.000514	0.000527	CcSEcCtD
Acamprosate—Malaise—Methylprednisolone—atopic dermatitis	0.000514	0.000527	CcSEcCtD
Acamprosate—Vertigo—Triamcinolone—atopic dermatitis	0.000513	0.000526	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000513	0.000526	CcSEcCtD
Acamprosate—Syncope—Triamcinolone—atopic dermatitis	0.000512	0.000525	CcSEcCtD
Acamprosate—Vertigo—Methylprednisolone—atopic dermatitis	0.000512	0.000525	CcSEcCtD
Acamprosate—Syncope—Methylprednisolone—atopic dermatitis	0.000511	0.000524	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCL27—atopic dermatitis	0.00051	0.0206	CbGpPWpGaD
Acamprosate—Discomfort—Hydrocortisone—atopic dermatitis	0.00051	0.000523	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000507	0.000519	CcSEcCtD
Acamprosate—Vomiting—Tacrolimus—atopic dermatitis	0.000504	0.000517	CcSEcCtD
Acamprosate—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000502	0.000514	CcSEcCtD
Acamprosate—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000501	0.000513	CcSEcCtD
Acamprosate—Rash—Tacrolimus—atopic dermatitis	0.0005	0.000513	CcSEcCtD
Acamprosate—Dermatitis—Tacrolimus—atopic dermatitis	0.0005	0.000512	CcSEcCtD
Acamprosate—Shock—Prednisolone—atopic dermatitis	0.000498	0.000511	CcSEcCtD
Acamprosate—Cough—Triamcinolone—atopic dermatitis	0.000498	0.000511	CcSEcCtD
Acamprosate—Headache—Tacrolimus—atopic dermatitis	0.000497	0.000509	CcSEcCtD
Acamprosate—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000495	0.000507	CcSEcCtD
Acamprosate—Convulsion—Triamcinolone—atopic dermatitis	0.000495	0.000507	CcSEcCtD
Acamprosate—Tachycardia—Prednisolone—atopic dermatitis	0.000494	0.000507	CcSEcCtD
Acamprosate—Convulsion—Methylprednisolone—atopic dermatitis	0.000493	0.000506	CcSEcCtD
Acamprosate—Hypertension—Triamcinolone—atopic dermatitis	0.000493	0.000505	CcSEcCtD
Acamprosate—Hypertension—Methylprednisolone—atopic dermatitis	0.000492	0.000504	CcSEcCtD
Acamprosate—Infection—Hydrocortisone—atopic dermatitis	0.000492	0.000504	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00049	0.000502	CcSEcCtD
Acamprosate—Shock—Hydrocortisone—atopic dermatitis	0.000487	0.000499	CcSEcCtD
Acamprosate—Myalgia—Triamcinolone—atopic dermatitis	0.000486	0.000498	CcSEcCtD
Acamprosate—Myalgia—Methylprednisolone—atopic dermatitis	0.000485	0.000497	CcSEcCtD
Acamprosate—Arthralgia—Methylprednisolone—atopic dermatitis	0.000485	0.000497	CcSEcCtD
Acamprosate—Anxiety—Methylprednisolone—atopic dermatitis	0.000483	0.000495	CcSEcCtD
Acamprosate—Tachycardia—Hydrocortisone—atopic dermatitis	0.000483	0.000495	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000482	0.000494	CcSEcCtD
Acamprosate—Skin disorder—Hydrocortisone—atopic dermatitis	0.000481	0.000493	CcSEcCtD
Acamprosate—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000481	0.000493	CcSEcCtD
Acamprosate—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000481	0.000493	CcSEcCtD
Acamprosate—Discomfort—Triamcinolone—atopic dermatitis	0.00048	0.000492	CcSEcCtD
Acamprosate—Discomfort—Methylprednisolone—atopic dermatitis	0.000479	0.000491	CcSEcCtD
Acamprosate—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—atopic dermatitis	0.000478	0.0193	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000478	0.00049	CcSEcCtD
Acamprosate—GABRA1—Ion channel transport—TRPV3—atopic dermatitis	0.000476	0.0192	CbGpPWpGaD
Acamprosate—Dry mouth—Triamcinolone—atopic dermatitis	0.000475	0.000487	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000475	0.0192	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000475	0.0192	CbGpPWpGaD
Acamprosate—Angioedema—Dexamethasone—atopic dermatitis	0.000473	0.000485	CcSEcCtD
Acamprosate—Angioedema—Betamethasone—atopic dermatitis	0.000473	0.000485	CcSEcCtD
Acamprosate—Anorexia—Hydrocortisone—atopic dermatitis	0.000472	0.000484	CcSEcCtD
Acamprosate—Nausea—Tacrolimus—atopic dermatitis	0.000471	0.000483	CcSEcCtD
Acamprosate—Confusional state—Methylprednisolone—atopic dermatitis	0.000469	0.000481	CcSEcCtD
Acamprosate—Immune system disorder—Prednisone—atopic dermatitis	0.000468	0.00048	CcSEcCtD
Acamprosate—Malaise—Betamethasone—atopic dermatitis	0.000467	0.000479	CcSEcCtD
Acamprosate—Malaise—Dexamethasone—atopic dermatitis	0.000467	0.000479	CcSEcCtD
Acamprosate—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000466	0.000478	CcSEcCtD
Acamprosate—Vertigo—Betamethasone—atopic dermatitis	0.000465	0.000477	CcSEcCtD
Acamprosate—Vertigo—Dexamethasone—atopic dermatitis	0.000465	0.000477	CcSEcCtD
Acamprosate—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000465	0.000477	CcSEcCtD
Acamprosate—Syncope—Dexamethasone—atopic dermatitis	0.000464	0.000476	CcSEcCtD
Acamprosate—Syncope—Betamethasone—atopic dermatitis	0.000464	0.000476	CcSEcCtD
Acamprosate—Infection—Triamcinolone—atopic dermatitis	0.000463	0.000475	CcSEcCtD
Acamprosate—Hypotension—Hydrocortisone—atopic dermatitis	0.000462	0.000474	CcSEcCtD
Acamprosate—Infection—Methylprednisolone—atopic dermatitis	0.000462	0.000474	CcSEcCtD
Acamprosate—Shock—Triamcinolone—atopic dermatitis	0.000458	0.00047	CcSEcCtD
Acamprosate—Insomnia—Prednisolone—atopic dermatitis	0.000458	0.00047	CcSEcCtD
Acamprosate—Alopecia—Prednisone—atopic dermatitis	0.000458	0.00047	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCL17—atopic dermatitis	0.000458	0.0185	CbGpPWpGaD
Acamprosate—Shock—Methylprednisolone—atopic dermatitis	0.000457	0.000469	CcSEcCtD
Acamprosate—Loss of consciousness—Betamethasone—atopic dermatitis	0.000455	0.000467	CcSEcCtD
Acamprosate—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000455	0.000467	CcSEcCtD
Acamprosate—Paraesthesia—Prednisolone—atopic dermatitis	0.000455	0.000466	CcSEcCtD
Acamprosate—Tachycardia—Triamcinolone—atopic dermatitis	0.000455	0.000466	CcSEcCtD
Acamprosate—Mental disorder—Prednisone—atopic dermatitis	0.000454	0.000465	CcSEcCtD
Acamprosate—Tachycardia—Methylprednisolone—atopic dermatitis	0.000454	0.000465	CcSEcCtD
Acamprosate—Skin disorder—Methylprednisolone—atopic dermatitis	0.000452	0.000463	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—atopic dermatitis	0.000451	0.000463	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000451	0.000462	CcSEcCtD
Acamprosate—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.00045	0.000462	CcSEcCtD
Acamprosate—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000449	0.000461	CcSEcCtD
Acamprosate—Convulsion—Dexamethasone—atopic dermatitis	0.000449	0.00046	CcSEcCtD
Acamprosate—Convulsion—Betamethasone—atopic dermatitis	0.000449	0.00046	CcSEcCtD
Acamprosate—Insomnia—Hydrocortisone—atopic dermatitis	0.000447	0.000459	CcSEcCtD
Acamprosate—Hypertension—Betamethasone—atopic dermatitis	0.000447	0.000459	CcSEcCtD
Acamprosate—Hypertension—Dexamethasone—atopic dermatitis	0.000447	0.000459	CcSEcCtD
Acamprosate—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000444	0.000456	CcSEcCtD
Acamprosate—Myalgia—Dexamethasone—atopic dermatitis	0.000441	0.000452	CcSEcCtD
Acamprosate—Myalgia—Betamethasone—atopic dermatitis	0.000441	0.000452	CcSEcCtD
Acamprosate—Anxiety—Betamethasone—atopic dermatitis	0.000439	0.000451	CcSEcCtD
Acamprosate—Anxiety—Dexamethasone—atopic dermatitis	0.000439	0.000451	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—atopic dermatitis	0.000436	0.000447	CcSEcCtD
Acamprosate—Discomfort—Dexamethasone—atopic dermatitis	0.000436	0.000447	CcSEcCtD
Acamprosate—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000436	0.000447	CcSEcCtD
Acamprosate—Hypotension—Methylprednisolone—atopic dermatitis	0.000434	0.000445	CcSEcCtD
Acamprosate—Pain—Prednisolone—atopic dermatitis	0.000433	0.000444	CcSEcCtD
Acamprosate—Decreased appetite—Hydrocortisone—atopic dermatitis	0.00043	0.000441	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000427	0.000438	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000424	0.000435	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000423	0.000434	CcSEcCtD
Acamprosate—Pain—Hydrocortisone—atopic dermatitis	0.000423	0.000434	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000423	0.000433	CcSEcCtD
Acamprosate—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000423	0.000433	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—atopic dermatitis	0.000421	0.000432	CcSEcCtD
Acamprosate—Insomnia—Methylprednisolone—atopic dermatitis	0.00042	0.000431	CcSEcCtD
Acamprosate—Infection—Dexamethasone—atopic dermatitis	0.00042	0.000431	CcSEcCtD
Acamprosate—Infection—Betamethasone—atopic dermatitis	0.00042	0.000431	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—atopic dermatitis	0.000419	0.000429	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—atopic dermatitis	0.000418	0.000429	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisolone—atopic dermatitis	0.000417	0.000428	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000417	0.000428	CcSEcCtD
Acamprosate—Anaemia—Prednisone—atopic dermatitis	0.000417	0.000427	CcSEcCtD
Acamprosate—Shock—Dexamethasone—atopic dermatitis	0.000416	0.000426	CcSEcCtD
Acamprosate—Shock—Betamethasone—atopic dermatitis	0.000416	0.000426	CcSEcCtD
Acamprosate—Dyspnoea—Triamcinolone—atopic dermatitis	0.000415	0.000426	CcSEcCtD
Acamprosate—Agitation—Prednisone—atopic dermatitis	0.000415	0.000425	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000414	0.000424	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000414	0.000424	CcSEcCtD
Acamprosate—Tachycardia—Dexamethasone—atopic dermatitis	0.000413	0.000423	CcSEcCtD
Acamprosate—Tachycardia—Betamethasone—atopic dermatitis	0.000413	0.000423	CcSEcCtD
Acamprosate—Angioedema—Prednisone—atopic dermatitis	0.000412	0.000423	CcSEcCtD
Acamprosate—Dyspepsia—Triamcinolone—atopic dermatitis	0.00041	0.000421	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000409	0.00042	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000409	0.000419	CcSEcCtD
Acamprosate—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000409	0.000419	CcSEcCtD
Acamprosate—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000408	0.000418	CcSEcCtD
Acamprosate—Malaise—Prednisone—atopic dermatitis	0.000407	0.000417	CcSEcCtD
Acamprosate—Vertigo—Prednisone—atopic dermatitis	0.000405	0.000416	CcSEcCtD
Acamprosate—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000405	0.000415	CcSEcCtD
Acamprosate—Syncope—Prednisone—atopic dermatitis	0.000404	0.000415	CcSEcCtD
Acamprosate—Anorexia—Betamethasone—atopic dermatitis	0.000403	0.000413	CcSEcCtD
Acamprosate—Anorexia—Dexamethasone—atopic dermatitis	0.000403	0.000413	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—atopic dermatitis	0.000402	0.000413	CcSEcCtD
Acamprosate—Pain—Triamcinolone—atopic dermatitis	0.000398	0.000409	CcSEcCtD
Acamprosate—Loss of consciousness—Prednisone—atopic dermatitis	0.000396	0.000407	CcSEcCtD
Acamprosate—Hypotension—Dexamethasone—atopic dermatitis	0.000395	0.000405	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—atopic dermatitis	0.000395	0.000405	CcSEcCtD
Acamprosate—Urticaria—Hydrocortisone—atopic dermatitis	0.000393	0.000403	CcSEcCtD
Acamprosate—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000391	0.000401	CcSEcCtD
Acamprosate—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000391	0.000401	CcSEcCtD
Acamprosate—Convulsion—Prednisone—atopic dermatitis	0.000391	0.000401	CcSEcCtD
Acamprosate—Hypertension—Prednisone—atopic dermatitis	0.000389	0.000399	CcSEcCtD
Acamprosate—GRIN2A—Reelin signaling pathway—MAPK8—atopic dermatitis	0.000388	0.0156	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000385	0.000395	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000385	0.000395	CcSEcCtD
Acamprosate—Myalgia—Prednisone—atopic dermatitis	0.000384	0.000394	CcSEcCtD
Acamprosate—Arthralgia—Prednisone—atopic dermatitis	0.000384	0.000394	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000384	0.000394	CcSEcCtD
Acamprosate—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000383	0.000393	CcSEcCtD
Acamprosate—Anxiety—Prednisone—atopic dermatitis	0.000383	0.000392	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—atopic dermatitis	0.000382	0.000392	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—atopic dermatitis	0.000382	0.000392	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000381	0.000391	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.00038	0.00039	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—atopic dermatitis	0.00038	0.000389	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—atopic dermatitis	0.00038	0.000389	CcSEcCtD
Acamprosate—Discomfort—Prednisone—atopic dermatitis	0.000379	0.000389	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000376	0.0152	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisolone—atopic dermatitis	0.000373	0.000383	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—atopic dermatitis	0.000372	0.000382	CcSEcCtD
Acamprosate—Dyspepsia—Dexamethasone—atopic dermatitis	0.000372	0.000382	CcSEcCtD
Acamprosate—Urticaria—Triamcinolone—atopic dermatitis	0.00037	0.00038	CcSEcCtD
Acamprosate—Urticaria—Methylprednisolone—atopic dermatitis	0.000369	0.000379	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCL11—atopic dermatitis	0.000369	0.0149	CbGpPWpGaD
Acamprosate—Body temperature increased—Triamcinolone—atopic dermatitis	0.000368	0.000378	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—atopic dermatitis	0.000368	0.000377	CcSEcCtD
Acamprosate—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000367	0.000377	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—atopic dermatitis	0.000367	0.000377	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—atopic dermatitis	0.000367	0.000377	CcSEcCtD
Acamprosate—Infection—Prednisone—atopic dermatitis	0.000366	0.000375	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000365	0.000374	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000365	0.000374	CcSEcCtD
Acamprosate—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000365	0.000374	CcSEcCtD
Acamprosate—Shock—Prednisone—atopic dermatitis	0.000362	0.000371	CcSEcCtD
Acamprosate—Pain—Betamethasone—atopic dermatitis	0.000361	0.000371	CcSEcCtD
Acamprosate—Pain—Dexamethasone—atopic dermatitis	0.000361	0.000371	CcSEcCtD
Acamprosate—Tachycardia—Prednisone—atopic dermatitis	0.000359	0.000368	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—atopic dermatitis	0.000358	0.000367	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—atopic dermatitis	0.000356	0.000365	CcSEcCtD
Acamprosate—Asthenia—Hydrocortisone—atopic dermatitis	0.000355	0.000364	CcSEcCtD
Acamprosate—Anorexia—Prednisone—atopic dermatitis	0.000351	0.00036	CcSEcCtD
Acamprosate—Pruritus—Hydrocortisone—atopic dermatitis	0.00035	0.000359	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—atopic dermatitis	0.000348	0.000357	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000348	0.000357	CcSEcCtD
Acamprosate—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000346	0.000354	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000346	0.000354	CcSEcCtD
Acamprosate—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000343	0.000352	CcSEcCtD
Acamprosate—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000342	0.000351	CcSEcCtD
Acamprosate—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000339	0.000347	CcSEcCtD
Acamprosate—Urticaria—Dexamethasone—atopic dermatitis	0.000336	0.000344	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—atopic dermatitis	0.000336	0.000344	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000335	0.000344	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—atopic dermatitis	0.000335	0.000344	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—atopic dermatitis	0.000334	0.000343	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—atopic dermatitis	0.000334	0.000343	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—atopic dermatitis	0.000334	0.000343	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—atopic dermatitis	0.000334	0.000343	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—atopic dermatitis	0.000334	0.000343	CcSEcCtD
Acamprosate—Asthenia—Methylprednisolone—atopic dermatitis	0.000334	0.000342	CcSEcCtD
Acamprosate—Insomnia—Prednisone—atopic dermatitis	0.000333	0.000341	CcSEcCtD
Acamprosate—Paraesthesia—Prednisone—atopic dermatitis	0.000331	0.000339	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—atopic dermatitis	0.00033	0.000338	CcSEcCtD
Acamprosate—GRIN2B—Reelin signaling pathway—MAPK8—atopic dermatitis	0.00033	0.0133	CbGpPWpGaD
Acamprosate—Pruritus—Methylprednisolone—atopic dermatitis	0.000329	0.000337	CcSEcCtD
Acamprosate—Dizziness—Hydrocortisone—atopic dermatitis	0.000327	0.000335	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—atopic dermatitis	0.000324	0.000332	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—atopic dermatitis	0.00032	0.000328	CcSEcCtD
Acamprosate—Rash—Prednisolone—atopic dermatitis	0.000319	0.000328	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—atopic dermatitis	0.000319	0.000327	CcSEcCtD
Acamprosate—GRIN2C—Alzheimers Disease—CASP8—atopic dermatitis	0.000318	0.0128	CbGpPWpGaD
Acamprosate—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000318	0.000326	CcSEcCtD
Acamprosate—Headache—Prednisolone—atopic dermatitis	0.000317	0.000325	CcSEcCtD
Acamprosate—Constipation—Prednisone—atopic dermatitis	0.000315	0.000323	CcSEcCtD
Acamprosate—Vomiting—Hydrocortisone—atopic dermatitis	0.000315	0.000323	CcSEcCtD
Acamprosate—Rash—Hydrocortisone—atopic dermatitis	0.000312	0.00032	CcSEcCtD
Acamprosate—Dermatitis—Hydrocortisone—atopic dermatitis	0.000312	0.00032	CcSEcCtD
Acamprosate—Headache—Hydrocortisone—atopic dermatitis	0.00031	0.000318	CcSEcCtD
Acamprosate—Dizziness—Triamcinolone—atopic dermatitis	0.000308	0.000316	CcSEcCtD
Acamprosate—Dizziness—Methylprednisolone—atopic dermatitis	0.000307	0.000315	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisone—atopic dermatitis	0.000303	0.000311	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—atopic dermatitis	0.000303	0.000311	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—atopic dermatitis	0.000303	0.000311	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000301	0.000309	CcSEcCtD
Acamprosate—Nausea—Prednisolone—atopic dermatitis	0.000301	0.000309	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCR3—atopic dermatitis	0.000301	0.0121	CbGpPWpGaD
Acamprosate—Pruritus—Dexamethasone—atopic dermatitis	0.000299	0.000307	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—atopic dermatitis	0.000299	0.000307	CcSEcCtD
Acamprosate—Vomiting—Triamcinolone—atopic dermatitis	0.000296	0.000304	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—CASP8—atopic dermatitis	0.000296	0.0119	CbGpPWpGaD
Acamprosate—Vomiting—Methylprednisolone—atopic dermatitis	0.000296	0.000303	CcSEcCtD
Acamprosate—Nausea—Hydrocortisone—atopic dermatitis	0.000294	0.000301	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCL22—atopic dermatitis	0.000294	0.0118	CbGpPWpGaD
Acamprosate—Rash—Triamcinolone—atopic dermatitis	0.000294	0.000301	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—atopic dermatitis	0.000293	0.000301	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—atopic dermatitis	0.000293	0.000301	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—atopic dermatitis	0.000293	0.0003	CcSEcCtD
Acamprosate—Urticaria—Prednisone—atopic dermatitis	0.000292	0.0003	CcSEcCtD
Acamprosate—Headache—Triamcinolone—atopic dermatitis	0.000292	0.000299	CcSEcCtD
Acamprosate—Headache—Methylprednisolone—atopic dermatitis	0.000291	0.000299	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—atopic dermatitis	0.000291	0.000298	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—atopic dermatitis	0.000291	0.000298	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—atopic dermatitis	0.000289	0.000297	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—atopic dermatitis	0.000289	0.000297	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—CCL27—atopic dermatitis	0.000288	0.0116	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.000284	0.0115	CbGpPWpGaD
Acamprosate—Dizziness—Dexamethasone—atopic dermatitis	0.00028	0.000287	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—atopic dermatitis	0.00028	0.000287	CcSEcCtD
Acamprosate—Nausea—Triamcinolone—atopic dermatitis	0.000277	0.000284	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—atopic dermatitis	0.000276	0.000283	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisone—atopic dermatitis	0.000271	0.000278	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—atopic dermatitis	0.000269	0.000276	CcSEcCtD
Acamprosate—Vomiting—Betamethasone—atopic dermatitis	0.000269	0.000276	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—NPS—atopic dermatitis	0.000268	0.0108	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—TAC1—atopic dermatitis	0.000268	0.0108	CbGpPWpGaD
Acamprosate—Rash—Dexamethasone—atopic dermatitis	0.000267	0.000273	CcSEcCtD
Acamprosate—Rash—Betamethasone—atopic dermatitis	0.000267	0.000273	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—atopic dermatitis	0.000266	0.000273	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—atopic dermatitis	0.000266	0.000273	CcSEcCtD
Acamprosate—Headache—Betamethasone—atopic dermatitis	0.000265	0.000272	CcSEcCtD
Acamprosate—Headache—Dexamethasone—atopic dermatitis	0.000265	0.000272	CcSEcCtD
Acamprosate—Asthenia—Prednisone—atopic dermatitis	0.000264	0.000271	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CXCR3—atopic dermatitis	0.000263	0.0106	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL27—atopic dermatitis	0.000262	0.0106	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.000262	0.0106	CbGpPWpGaD
Acamprosate—Pruritus—Prednisone—atopic dermatitis	0.00026	0.000267	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000259	0.0105	CbGpPWpGaD
Acamprosate—Diarrhoea—Prednisone—atopic dermatitis	0.000252	0.000258	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—atopic dermatitis	0.000251	0.000257	CcSEcCtD
Acamprosate—Nausea—Betamethasone—atopic dermatitis	0.000251	0.000257	CcSEcCtD
Acamprosate—Dizziness—Prednisone—atopic dermatitis	0.000243	0.00025	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—CASP8—atopic dermatitis	0.000243	0.00981	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—IL1B—atopic dermatitis	0.000241	0.00974	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL17—atopic dermatitis	0.000235	0.00947	CbGpPWpGaD
Acamprosate—Vomiting—Prednisone—atopic dermatitis	0.000234	0.00024	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—BDNF—atopic dermatitis	0.000233	0.0094	CbGpPWpGaD
Acamprosate—Rash—Prednisone—atopic dermatitis	0.000232	0.000238	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—atopic dermatitis	0.000232	0.000238	CcSEcCtD
Acamprosate—Headache—Prednisone—atopic dermatitis	0.000231	0.000236	CcSEcCtD
Acamprosate—GRIN2D—Alzheimers Disease—IL1B—atopic dermatitis	0.000224	0.00906	CbGpPWpGaD
Acamprosate—Nausea—Prednisone—atopic dermatitis	0.000219	0.000224	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—IL4—atopic dermatitis	0.000216	0.00873	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL10—atopic dermatitis	0.000212	0.00857	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—CASP8—atopic dermatitis	0.000212	0.00855	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CASP8—atopic dermatitis	0.000207	0.00834	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—BDNF—atopic dermatitis	0.000199	0.00801	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—BDNF—atopic dermatitis	0.000194	0.00781	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000193	0.00779	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000191	0.00772	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00019	0.00765	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL11—atopic dermatitis	0.000189	0.00764	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FCER2—atopic dermatitis	0.000187	0.00753	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.000186	0.00752	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—atopic dermatitis	0.000184	0.00744	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL5—atopic dermatitis	0.000183	0.00738	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.000178	0.00718	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NGF—atopic dermatitis	0.000176	0.00711	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—atopic dermatitis	0.000175	0.00707	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL22—atopic dermatitis	0.000174	0.007	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NGF—atopic dermatitis	0.000172	0.00693	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR3—atopic dermatitis	0.00017	0.00685	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000166	0.00669	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.000165	0.00667	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCR5—atopic dermatitis	0.000165	0.00665	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—atopic dermatitis	0.000163	0.00657	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.000161	0.0065	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—atopic dermatitis	0.000161	0.00649	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—atopic dermatitis	0.000157	0.00632	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL27—atopic dermatitis	0.000155	0.00624	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR3—atopic dermatitis	0.000154	0.00622	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—TAC1—atopic dermatitis	0.000151	0.00611	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—NPS—atopic dermatitis	0.000151	0.00611	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000149	0.00599	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.000148	0.00598	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—NFKBIA—atopic dermatitis	0.000145	0.00587	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—NFKBIA—atopic dermatitis	0.000142	0.00572	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL5—atopic dermatitis	0.000141	0.00568	CbGpPWpGaD
Acamprosate—GABRB3—Orphan transporters—PPARA—atopic dermatitis	0.000141	0.00568	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL17—atopic dermatitis	0.000139	0.0056	CbGpPWpGaD
Acamprosate—GABRG2—Orphan transporters—PPARA—atopic dermatitis	0.000138	0.00557	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TAC1—atopic dermatitis	0.000138	0.00555	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NPS—atopic dermatitis	0.000138	0.00555	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCR3—atopic dermatitis	0.000135	0.00544	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—atopic dermatitis	0.000134	0.0054	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BDNF—atopic dermatitis	0.000131	0.00529	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—atopic dermatitis	0.000131	0.00528	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL5—atopic dermatitis	0.000128	0.00516	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIF3A—atopic dermatitis	0.000124	0.00499	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—atopic dermatitis	0.000122	0.00491	CbGpPWpGaD
Acamprosate—GABRA1—Orphan transporters—PPARA—atopic dermatitis	0.000121	0.00487	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00012	0.00484	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—atopic dermatitis	0.000117	0.00471	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—atopic dermatitis	0.000117	0.00471	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NGF—atopic dermatitis	0.000116	0.00469	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—atopic dermatitis	0.000116	0.00469	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—atopic dermatitis	0.000114	0.00459	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL11—atopic dermatitis	0.000112	0.00451	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CMA1—atopic dermatitis	0.000112	0.00451	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL10—atopic dermatitis	0.000109	0.0044	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.000106	0.00426	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT6—atopic dermatitis	0.000105	0.00424	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCL5—atopic dermatitis	0.000103	0.00417	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.000101	0.00406	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—atopic dermatitis	9.96e-05	0.00402	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	9.92e-05	0.004	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	9.73e-05	0.00392	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NFKBIA—atopic dermatitis	9.59e-05	0.00387	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL5—atopic dermatitis	9.38e-05	0.00379	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NGF—atopic dermatitis	9.36e-05	0.00378	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	9.33e-05	0.00376	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—atopic dermatitis	9.31e-05	0.00376	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.27e-05	0.00374	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK8—atopic dermatitis	9.12e-05	0.00368	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR3—atopic dermatitis	9.12e-05	0.00368	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—atopic dermatitis	8.89e-05	0.00359	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—atopic dermatitis	8.46e-05	0.00341	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—atopic dermatitis	8.45e-05	0.00341	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TAC1—atopic dermatitis	8.12e-05	0.00328	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPS—atopic dermatitis	8.12e-05	0.00328	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCR3—atopic dermatitis	7.97e-05	0.00321	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL5—atopic dermatitis	7.55e-05	0.00305	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	7.09e-05	0.00286	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.96e-05	0.00281	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—atopic dermatitis	6.83e-05	0.00276	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—atopic dermatitis	6.77e-05	0.00273	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL10—atopic dermatitis	6.44e-05	0.0026	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARA—atopic dermatitis	6.13e-05	0.00247	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.09e-05	0.00246	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—atopic dermatitis	6.02e-05	0.00243	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARA—atopic dermatitis	5.98e-05	0.00241	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	5.63e-05	0.00227	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL5—atopic dermatitis	5.54e-05	0.00224	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	5.51e-05	0.00222	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—atopic dermatitis	5.46e-05	0.0022	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—atopic dermatitis	5.38e-05	0.00217	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	5.28e-05	0.00213	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGF—atopic dermatitis	5.13e-05	0.00207	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—atopic dermatitis	5.11e-05	0.00206	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—atopic dermatitis	4.99e-05	0.00201	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—atopic dermatitis	4.88e-05	0.00197	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKBIA—atopic dermatitis	4.23e-05	0.00171	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.83e-05	0.00155	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.44e-05	0.00139	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.37e-05	0.00136	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.09e-05	0.00125	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—atopic dermatitis	3.04e-05	0.00123	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—atopic dermatitis	3.02e-05	0.00122	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—atopic dermatitis	2.97e-05	0.0012	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.95e-05	0.00119	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—atopic dermatitis	2.89e-05	0.00116	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—atopic dermatitis	2.87e-05	0.00116	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—atopic dermatitis	2.69e-05	0.00109	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—atopic dermatitis	2.66e-05	0.00107	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—atopic dermatitis	2.62e-05	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—atopic dermatitis	2.17e-05	0.000876	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—atopic dermatitis	2.12e-05	0.000854	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—atopic dermatitis	1.7e-05	0.000684	CbGpPWpGaD
